Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) EPS (Basic) (2016 - 2025)

Abeona Therapeutics (ABEO) has 15 years of EPS (Basic) data on record, last reported at -$0.13 in Q3 2025.

  • For Q3 2025, EPS (Basic) rose 81.16% year-over-year to -$0.13; the TTM value through Sep 2025 reached $1.62, up 179.02%, while the annual FY2024 figure was -$1.55, 38.74% up from the prior year.
  • EPS (Basic) reached -$0.13 in Q3 2025 per ABEO's latest filing, down from $2.13 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $2.13 in Q2 2025 and bottomed at -$21.17 in Q4 2021.
  • Average EPS (Basic) over 5 years is -$2.22, with a median of -$0.54 recorded in 2023.
  • Peak YoY movement for EPS (Basic): crashed 11661.11% in 2021, then skyrocketed 384.09% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at -$21.17 in 2021, then soared by 102.46% to $0.52 in 2022, then plummeted by 223.08% to -$0.64 in 2023, then surged by 78.12% to -$0.14 in 2024, then grew by 7.14% to -$0.13 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were -$0.13 in Q3 2025, $2.13 in Q2 2025, and -$0.24 in Q1 2025.